Additionally, the proteinatlas.org indicates that the loss of SATB1 or weak expression in tumor tissue was associated with worse overall survival for renal cell carcinoma and pancreatic cancer, while a higher expression is associated with longer overall survival31. Here, SATB1 is linked to neoplasm.